Healthy volunteers test two versions of a promising heart failure drug

NCT ID NCT07717749

Not yet recruiting Knowledge-focused Sponsor: Addpharma Inc. Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests two different formulations of an experimental drug called AD-118 in healthy adults aged 19 to 64. Participants receive a single dose of each version in a random order, and researchers measure how the drug moves through the body and check for side effects. The goal is to see which formulation is safer and better absorbed before testing it in people with chronic heart failure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an experimental drug called AD-118
What this could lead to: If successful, this study could help determine which formulation of AD-118 is safer and better absorbed, supporting future trials for chronic heart failure.
What could go wrong: This is an early-stage, small study in healthy volunteers, not patients. The drug may not work as hoped in later trials or may have unforeseen side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEART FAILURE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

H Plus Yangji Hospital

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.